Press release
Neoantigen Peptides Manufacturing Market Study Analysis with Forecast to 2031
The Neoantigen Peptides Manufacturing Market is expected to grow at a 16.0 % CAGR during the forecast period for 2023-2031.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1270
Neoantigen peptides are produced by the somatic mutation of a particular tumour. These peptides stimulate a cancer cell's immune system during the production of vaccines based on neoantigens. Personalized neoantigen peptides are synthesized, which produces the T-cell population. T-Cell Receptors (TCRs) recognize the HLA molecule to which neoantigen peptides are bound during synthesis. Neoantigens are a recognized paradigm for delivering cancer vaccines, and other forms of immunotherapy are being investigated to treat numerous types of cancer.
The evolution of neoantigen production algorithms will enable the consistent production of peptides for cancer research and drug development. Significant market factors for Neoantigen peptide production include:
• Increased successful clinical trials.
• The prevalence of cancer and chronic diseases.
• The demand for long-term treatments.
In addition, advances in biotechnology research will facilitate the investigation of personalized neoantigen peptides. External funding for the research and development of cancer pharmaceuticals also drives the market upward.
However, the market will be constrained by the increased cost of devising and developing personalized cancer therapeutics and the delay in clinical trials caused by COVID-19. The demand for neoantigen production is anticipated to expand due to reduced process time and cost, treatment gaps, partnerships and collaboration between various healthcare stakeholders, and data analytics. Compared to Asia and Europe, North America dominates the market, resulting in rapid research and development, a rise in cancer incidence, and increased demand for enhanced treatment procedures.
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1270
Major key players operating in the neoantigen peptide manufacturing market are CPC Scientific Inc, Polypeptide group, Genscript Biotech, Kaneka Eurogentec S.A., Vivitide, Almac, BCN Peptides, Creative Peptides, Pepscan, Provepharm, Creosalus, Gyros Protein Technologies, Other Prominent Players.
Key Developments In The Market:
• In Mar 2022, Pepscan announced that its specialists would manufacture the personalized peptide pools to treat cancer patients in Evaxion's phase IIb trial. Evaxion Biotech, a clinical-stage biotechnology company, recently published the initial results of the peptide-based personalized therapy EVX-01 in patients with metastatic melanoma. Pepscan had provided the personalized peptide pools for its phase I/IIa trial.
• In January 2021, Genocea announced a cancer discovery publication. The advantages of neoantigen identification using the ATLAS platform and this discovery strengthens neoantigen immunotherapies by theoretically certifying that they target the correct neoantigens while removing Inhibigens.
• In Apr 2020, GenScript company announced the commercial launch of its neoantigen peptide synthesis service for personalized cancer therapeutics. GenScript partnered with several T-cell therapy and personalized cancer vaccine companies to develop the infrastructure for reliably manufacturing complex peptides for its neoantigen peptide synthesis platform.
• In Feb 2019, CPC Scientific Inc., a leading global CDMO specializing in synthetic peptide manufacturing, announced today that they would manufacture GMP-grade neoantigen peptides for investigators at UNC Lineberger Comprehensive Cancer Center (LCCC) for individualized immunotherapy. CPC Scientific will supply GMP-grade neoantigen peptides, the sequences of which will be determined via genomics and bioinformatics, for use in the LCCC therapeutic neoantigen vaccine program.
• In Jan 2019, Almac group (CDMO)added a second stream for high output GMP peptide manufacture to its facility in Edinburgh, Scotland. The site manufactures Neoantigen-derived peptides to produce its personalized cancer vaccines.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1270
Market Segments
Global Neoantigen Peptides Manufacturing Market, by Scale of operations, 2020-2030 (Value US$ Mn)
• Research/Preclinical
• Clinical
• Commercial
Global Neoantigen Peptides Manufacturing Market, by End-users 2020-2030 (Value US$ Mn)
• Pharmaceutical/Vaccine developers companies
• Contract Research Organizations (CRO)
• Academic and research institutes
Global Neoantigen Peptides Manufacturing Market, by Region, 2020-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Neoantigen Peptides Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Neoantigen Peptides Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Neoantigen Peptides Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Neoantigen Peptides Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Neoantigen Peptides Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
> To receive a comprehensive analysis of the prospects for the global Neoantigen Peptides Manufacturing market
> To receive an industry overview and future trends of the Neoantigen Peptides Manufacturing market
> To analyze the Neoantigen Peptides Manufacturing market drivers and challenges
> To get information on the Neoantigen Peptides Manufacturing market size (Value US$ Mn) forecast to 2030
> Significant investments, mergers & acquisitions in the Neoantigen Peptides Manufacturing market industry
Other Related Reports Published by InsightAce Analytic:
Global Peptide CDMO (Pharmaceutical) Market
Global Neoantigen Cancer Vaccine Market
Global Protein Design and Engineering Market
Global Next-Generation Biomanufacturing Market
Global Biopharmaceutical Excipient Manufacturing Market
Global mRNA Synthesis and Manufacturing Services Market
For More Information: https://www.insightaceanalytic.com/report/global-neoantigen-peptides-manufacturing-market/1270
Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
loaction icon
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email iconinfo@insightaceanalytic.com
call icon
North America:
+1 551 226 6109
Asia:
+91 79 72967118
Contact Us:
Dhanraj Zurange
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neoantigen Peptides Manufacturing Market Study Analysis with Forecast to 2031 here
News-ID: 3382185 • Views: …
More Releases from Insightace analytic
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"
The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%…
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031
"Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by…
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals…
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031"
The Global Data Center Liquid Cooling Market is estimated…
More Releases for Neoantigen
Neoantigen Cancer Vaccine Market Size, Share & CAGR 69.43% to 2034
What is driving the explosive growth of the neoantigen cancer vaccine market?
The neoantigen cancer vaccine market is seeing one of the most rapid growth trajectories in modern oncology. With a market size of USD 116.74 million in 2024, it is projected to reach USD 22,757.41 million by 2034, growing at a CAGR of 69.43%. This unprecedented growth is being fueled by advancements in genomic technologies, the success of mRNA platforms…
Rising Incidence Of Cancer Cases Drives Growth In The Neoantigen Targeted Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Neoantigen Targeted Therapies Industry Market Size Be by 2025?
There has been a notable expansion in the market size of neoantigen targeted therapies in the last few years. This market is projected to grow from $3.4 billion in 2024 to $4.72 billion in 2025, experiencing a…
Neoantigen Targeted Therapies Market: Towering Growth, Key Players, and Emerging …
Projected Market Size of The Global Neoantigen Targeted Therapies Market and Its Growth Rate
The neoantigen targeted therapies market has been growing significantly and is projected to continue this trend.
•2024 Market Size: $3.4 billion
•2025 Market Size: $4.72 billion (38.7% CAGR)
•2029 Market Size: $16.01 billion (35.7% CAGR)
These developments owe much to advancements in genomic sequencing, immunotherapy evolution, understanding tumor immunology, molecular profiling advancements among others.
What Is Driving The Growth In The Neoantigen…
Neoantigen Peptide Manufacturing Market Research Report 2023 - InsightAce Analyt …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neoantigen Peptides Manufacturing Market by Scale of operations (Research/Preclinical, Clinical, Commercial), by End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations (CRO), Academic and Research Institutes)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Neoantigen Peptides Manufacturing market is expected to grow with CAGR of 16.4% during…
Neoantigen Cancer Vaccine Market Will Touch USD 1,322.8 Million by 2030
According to P&S Intelligence, the global neoantigen cancer vaccine market was valued at USD 24.4 million in 2022, and it will advance at a mammoth 67.6% compound annual growth rate, to touch USD 1,322.8 million, by 2030.
The key factor boosting the advancement of the industry include the mounting incidence of cancer and surging research activities all over the world. Moreover, because of the growing importance of personalized treatments of…
Neoantigen Targeted Therapies Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Neoantigen Targeted Therapies Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Neoantigen Targeted Therapies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neoantigen Targeted Therapies with respect…
